GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
Why GLP-1 Drugs May Increase Gout Risk The study also found a slightly higher risk of gout among GLP-1 users
Advanced Interventional Musculoskeletal Therapies Incorporate image-guided precision injections, nerve modulation techniques, and integrative biologic approaches
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
When combined, distinguishing which substance causes which effect becomes harder
Contact the blood center for religious exceptions
